logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Hidehisa Saeki

Nippon Medical School

57H指数
607论文数
1.3W被引数
收录论文 185
发表时间
logo
High-Salt Diet Exacerbates Murine Imiquimod-Induced Psoriasis-like Dermatitis via Activation of Serum- and Glucocorticoid-Inducible Kinase 1高盐饮食通过激活血清和糖皮质激素诱导激酶1加剧小鼠咪喹莫特诱导的银屑病样皮炎
errInternational Journal of Molecular Sciences
IF4.9
err2026-09-14
err0
errOAAI
errMai Yoshida; Teppei Hagino; Manami Yoneyama; Hidehisa Saeki; Naoko Kanda
err分享
err收藏
Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study日本成人中重度特应性皮炎患者结节性瘙痒症的表征：一项为期2年的观察性研究
errThe Journal of Dermatology
IF0
err2026-07-02
err0
errOAAI
errYoko Kataoka; Takafumi Etoh; Hidehisa Saeki; Norito Katoh; Satoshi Teramukai; Yuki Tajima; Kwinten Bosman; Marius Ardeleanu; Kazuhiko Arima
err分享
err收藏
Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study)日本多中心回顾性研究（ROADMAP研究）：乌帕替尼在特应性皮炎患者中的真实世界缓解维持
errThe Journal of Dermatology
IF0
err2026-06-04
err0
errOAAI
errYuichiro Tsunemi; Atsuyuki Igarashi; Takeshi Ishido; Hidehisa Saeki
err分享
err收藏
One hundred and four-week real-world effectiveness of deucravacitinib 6 mg for genital, scalp, and nail psoriasis: A prospective study in Japan德卡鲁卡替尼6 mg治疗生殖器、头皮和指甲银屑病的104周真实世界有效性：一项日本前瞻性研究
errJournal of the American Academy of Dermatology
IF11.8
err2026-03-05
err0
PREAI
errTeppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏
A 144-week real-world outcomes of upadacitinib 30 mg for atopic dermatitis in poor responders to 15 mg乌帕替尼30 mg治疗对15 mg应答不佳的特应性皮炎患者的144周真实世界结局。
errJournal of the American Academy of Dermatology
IF11.8
err2026-03-03
err0
PREAI
errTeppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏
PI3Kγ Deficiency Suppresses Cutaneous Squamous Cell Carcinoma Formation by Modulating the Tumour Microenvironment Rather Than by Directly Regulating Keratinocyte Proliferation
errExperimental Dermatology
IF3.1
err2026-02-06
err0
errOAAI
errAya Toyoshima; Natsuko Noguchi; Tomoko Suzuki; Takako Kuroki; Masami Kagaya; Fumino Oda; Michihiro Kono; Junko Sasaki; Takehiko Sasaki; Hidehisa Saeki; Shin-Ichi Osada
err分享
err收藏
Effectiveness of Anti-IL-13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48-Week Outcomes by Lebrikizumab and Tralokinumab抗IL-13抗体对特应性皮炎头颈部病变的有效性：莱博利珠单抗和特拉利珠单抗48周疗效
errJOURNAL OF DERMATOLOGY
IF2.7
err2026-02-01
err0
PREAI
errShiba, Mizuki; Hagino, Teppei; Uchiyama, Akihiko; Saeki, Hidehisa; Fujimoto, Eita; Motegi, Sei-ichiro; Kanda, Naoko
err分享
err收藏
Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24-week real-world case seriesnemolizumab治疗儿童特应性皮炎的疗效与安全性：一项为期24周的真实世界病例系列研究
errJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
err2025-11-01
err0
PREAI
errTakahashi, Yohei; Hagino, Teppei; Saeki, Hidehisa; Fujimoto, Eita; Kanda, Naoko
err分享
err收藏
A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis一项关于迪芬拉司软膏的3期、长期、开放标签研究，旨在评估其在日本特应性皮炎婴儿中的有效性与安全性。
errDermatology and Therapy
IF4.2
err2025-10-31
err0
errOAAI
errHidehisa Saeki; Yukihiro Ohya; Naoko Baba; Tomomi Imamura; Daisuke Yokota; Hidetsugu Tsubouchi
err分享
err收藏
Letter: Real-World 48-Week Outcomes of Tralokinumab Treatment for Prurigo Nodularis–Like Atopic Dermatitis: A Japanese Retrospective Study信函：真实世界中特拉利昔单抗治疗类结节性痒疹特应性皮炎的48周结果：一项日本回顾性研究
errDermatitis
IF3.2
err2025-10-13
err0
PREAI
errChisato Hayakawa; Teppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏
Exacerbated signs of atopic dermatitis with gut dysbiosis predominate in male than in female adult patients肠道菌群失调会加剧特应性皮炎的症状，其在成年男性患者中比女性患者更为常见。
errALLERGOLOGY INTERNATIONAL
IF6.7
err2025-10-01
err0
errOAAI
errIchiyama, Susumu; Ohkusu-Tsukada, Kozo; Saeki, Hidehisa
err分享
err收藏
A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus -experienced patients特应性皮炎患者接受特立妥单抗治疗的48周真实世界疗效：系统治疗初治患者与经治患者的对比研究
errJournal of the American Academy of Dermatology
IF11.8
err2025-09-15
err0
PREAI
errTeppei Hagino; Akihiko Uchiyama; Keiji Kosaka; Takeshi Araki; Hidehisa Saeki; Eita Fujimoto; Sei-ichiro Motegi; Naoko Kanda
err分享
err收藏
A 104-Week Real-World Outcome of Bimekizumab Treatment for Psoriasis: Biologic-Naïve Versus -Experienced PatientsBimekizumab治疗银屑病的104周真实世界结局：生物制剂初治患者与有生物制剂使用经验患者的比较
errJOURNAL OF DERMATOLOGY
IF2.7
err2025-09-01
err0
PREAI
errTakahashi, Yohei; Hagino, Teppei; Saeki, Hidehisa; Fujimoto, Eita; Kanda, Naoko
err分享
err收藏
Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics前瞻性、开放标签、多中心研究：阿普米沙特作为生物制剂缓解期银屑病患者维持治疗的疗效
errJOURNAL OF DERMATOLOGY
IF2.7
err2025-09-01
err0
PREAI
errKamiya, Koji; Yamaguchi, Yukie; Saeki, Hidehisa; Kodera, Masanari; Tada, Yayoi; Morita, Akimichi; Abe, Masatoshi; Okubo, Yukari; Sano, Shigetoshi; Ohtsuki, Mamitaro
err分享
err收藏
Maintenance of Early Responses and Delayed Responses to Tralokinumab Treatment in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study中重度特应性皮炎患者对Tralokinumab治疗的早期和延迟反应的维持：一项为期48周的真实世界研究
errDERMATITIS
IF3.2
err2025-09-01
err0
PREAI
errOkano, Fumisa; Hagino, Teppei; Uchiyama, Akihiko; Kosaka, Keiji; Araki, Takeshi; Saeki, Hidehisa; Fujimoto, Eita; Motegi, Sei-ichiro; Kanda, Naoko
err分享
err收藏
Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis特应性皮炎躯干和四肢皮损从外用皮质类固醇转换使用delgocitinib软膏后的治疗满意度、有效性与安全性。
errdermatology
IF0
err2025-08-27
err0
errOAAI
errMasatoshi Abe; Atsuyuki Igarashi; Hiroyuki Kitajima; Hiroyuki Toyama; Kenji Kabashima; Hidehisa Saeki
err分享
err收藏
Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene全基因组测序揭示了与银屑病相关的罕见和结构变异，并确定了CERCAM为风险基因
errCell Genomics
IF9
err2025-08-22
err0
errOAAI
errKyuto Sonehara; Rei Watanabe; Yutaka Matsumura; Yuichi Mitsui; Yosuke Ogawa; Kaori Odomari; Saori Sakaue; Shinichi Namba; Mariko Komuro; Mio Edamoto; Junya Watanabe; Tomomitsu Hirota; Noriko Arase; Yuumi Nakamura; Kimiko Nakajima; Takashi Okamoto; Rika Nishikawa; Kenichi Yamamoto; Ken Suzuki; Toshihiro Kishikawa; Ryuya Edahiro; Yuya Shirai; Tatsuhiko Naito; Noah Sasa; Yosuke Ishitsuka; Junichi Furuta; Kayo Kunimoto; Ikko Kajihara; Satoshi Fukushima; Hideaki Miyachi; Hiroyuki Matsue; Masahiro Kamata; Mami Momose; Ippei Miyagawa; Hiroaki Tanaka; Masanobu Ueno; Toshinori Bito; Hiroshi Nagai; Tetsuya Ikeda; Tatsuya Horikawa; Atsuko Adachi; Tsukasa Matsubara; Emi Nishida; Koichi Matsuda; Nobuhiro Shojima; Ikuma Nakagawa; Yoshihide Asano; Shinichi Sato; Shinichi Imafuku; Yayoi Tada; Chikako Nishigori; Masatoshi Jinnin; Hironobu Ihn; Akihiko Asahina; Hidehisa Saeki; Toshimasa Yamauchi; Takashi Kadowaki; Tatsuyoshi Kawamura; Shinji Shimada; Ichiro Katayama; Koichiro Higasa; Emiko Noguchi; Shigetoshi Sano; Yoshiya Tanaka; Fumihiko Matsuda; Atsushi Kumanogoh; Mayumi Tamari; Takashi Satoh; Manabu Fujimoto; Akimichi Morita; Yukinori Okada
err分享
err收藏
Predictive Factors for Poor Responders to Lebrikizumab in Real-World Treatment for Atopic Dermatitis: Transition of Clinical and Laboratory Indexes特应性皮炎真实世界治疗中对lebrikizumab反应不佳的预测因素：临床和实验室指标的变化
errdermatitis
IF0
err2025-08-12
err0
PREAI
errMizuki Shiba; Teppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏
Letter: Long-Term Effectiveness of Tralokinumab in Patients With Atopic Dermatitis Refractory to Dupilumab: A 48-Week Real-World Study信函：曲库珠单抗在Dupilumab难治性特应性皮炎患者中的长期有效性：一项为期48周的真实世界研究
errdermatitis
IF0
err2025-08-11
err0
PREAI
errReo Kamohara; Teppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏
Letter: Transition of Hematological Indexes in 36-Week Treatment with Lebrikizumab for Atopic Dermatitis: A Real-World Prospective Japanese Study信函：Lebrikizumab治疗特应性皮炎36周期间血液学指标的变化：一项日本真实世界前瞻性研究
errdermatitis
IF0
err2025-08-08
err0
PREAI
errFumisa Okano; Teppei Hagino; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
T
Takashi Kadowaki
H 指数: 153 · 论文数: 1.4K
M
Michiaki Kubo
H 指数: 138 · 论文数: 1.1K
K
Kouji Matsushima
H 指数: 130 · 论文数: 787
K
Ko Okumura
H 指数: 125 · 论文数: 1.2K
T
Tatsuhiko Tsunoda
H 指数: 120 · 论文数: 594
查看更多